Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
| Conditions: | Solid Tumor|Lymphoma |
| Start Date: | June 1, 2006 |
| Phase: | Phase I |
| Status: | Recruiting |
| NCT ID: | NCT00413075 |
| Study Type: | Interventional |
| Intervention: | Drug: belinostat |
| Study Design: | Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | TopoTarget A/S|Spectrum Pharmaceuticals, Inc |
| Ages: | Adult|Senior |
| Enrollment: | 100 |
| Funded By: | Industry |
| First Received: | December 18, 2006 |
| End Date: | December 1, 2010 |
| Last Updated: | May 5, 2010 |
| Last Verified: | May 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
